Implanet has obtained marketing clearance from the US and European regulatory authorities to market its new Jazz Braid.
The new Jazz Braid is an updated version, designed in response to surgeon feedback since the initial product launch in late 2013. According to a company release, technical characteristics have been optimised, with part of the band now ultrasonically bonded, improving the Band’s handling and stability. Compatible with the current instrument system, the braid will continue to interface with the proprietary Jazz tensioning system.
Ludovic Lastennet, chief executive officer of Implanet, adds: “The commercial launch of this new version of the Jazz Braid follows the granting of the 10th successive 510(K) clearance by US Food and Drug Administration.”